Trovagene develops drug-based therapeutics that target cell division for the treatment of leukemias, lymphomas, and solid tumor cancers... Read more
Cardiff Oncology CEO: Mark Erlander

CEO

Mark Erlander

CEO Approval Rating

- -/100

Annual Revenue
$ < 1M
Employees
20
Funding
$50M

Cardiff Oncology Competitors

1bluebird bio
2Inovio
3Genecast
4Genomic Health
5NuProbe
6RareCyte
7MolecularMD
8Foundation Medicine
9Sangamo
10Biocept

Trending Companies